Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

February 16, 2023

Targeted therapy for neuroendocrine tumors

Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.

By Kelsey Pinckard
February 16, 2023

Patient undergoes novel therapy to treat pancreatic cancer

Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.

By Tom Wilemon
February 16, 2023

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt’s Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.

By Tom Wilemon
Cancer patient Jayden Bailey, left, designed the shoes worn by Vanderbilt men’s basketball coach Jerry Stackhouse during the recent Coaches vs. Cancer “Suits and Sneakers” basketball game.
February 9, 2023

Patient designs shoes for Coaches vs. Cancer game

Vanderbilt patient Jayden Bailey designed a special pair of Nike Air Max shoes for Jerry Stackhouse, coach of the Vanderbilt University men’s basketball team, to wear during the Jan. 24 Coaches vs. Cancer “Suits and Sneakers” basketball game.

By Christina Echegaray
Krista Kuhnert-Gainer, ACNP, shows off the sign her colleagues made to celebrate her reaching 20,000 bone marrow biopsies performed.
February 9, 2023

‘Biopsy Queen’ reaches milestone number of procedures

Vanderbilt-Ingram Cancer Center’s Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.

By Tom Wilemon
February 9, 2023

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

By Craig Boerner
February 9, 2023

Vanderbilt-Ingram joins CancerLinQ quality initiative

Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.
By Tom Wilemon
February 6, 2023

Berlin named director of Division of Hematology and Oncology

Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.
By Tom Wilemon
January 19, 2023

Surgeons target pancreatic cancer with electrons using new technology

Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
By Tom Wilemon
January 9, 2023

Novel lung cancer biomarker

Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.
By Leigh MacMillan
January 5, 2023

New approach outperforms existing cancer susceptibility models

A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
By Tom Wilemon
December 8, 2022

Lovly receives Asclepios Award from GO2 for Lung Cancer

Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
By Tom Wilemon
December 1, 2022

“VUMC Remembers” virtual memorial service honors patients who died in the past year

The program features speakers from different hospital departments, staff testimonials of patients at the end of their lives, a reading of loved ones’ names and special music.
By Matt Batcheldor
1 2 3 4 5 6 … 55